A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen-Reference-Cited by-同舟云学术

A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen

Published:2016-02 Issue: Volume:292 Page:40-55
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Michaut Anaïs,Le Guillou Dounia,Moreau Caroline,Bucher Simon,McGill Mitchell R.,Martinais Sophie,Gicquel Thomas,Morel Isabelle,Robin Marie-Anne,Jaeschke Hartmut,Fromenty Bernard

Funder

INSERM

Fonds d'Innovation pour la Recherche of the CHU of Rennes

Conseil Régional de Bretagne

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference90 articles.

1. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human;Andersson;Expert Opin. Drug Metab. Toxicol.,2012

2. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells;Aninat;Drug Metab. Dispos.,2006

3. Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells;Anthérieu;Hepatology,2013

4. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells;Anthérieu;Drug Metab. Dispos.,2010

5. Optimization of the HepaRG cell model for drug metabolism and toxicity studies;Anthérieu;Toxicol. in Vitro,2012

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of total saikosaponins on CYP3A4 and CYP1A2 in HepaRG cells;Experimental and Therapeutic Medicine;2024-03-21

2. 3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments;Toxicology in Vitro;2024-02

3. SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH;JHEP Reports;2024-01

4. Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis;Frontiers in Pharmacology;2023-10-19

5. In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity;Archives of Toxicology;2023-04-12